ES2053815T3 - Preparacion farmaceutica con liberacion prolongada de una dihidropiridina y un antagonista de un beta-adrenorreceptor y un procedimiento para su preparacion. - Google Patents
Preparacion farmaceutica con liberacion prolongada de una dihidropiridina y un antagonista de un beta-adrenorreceptor y un procedimiento para su preparacion.Info
- Publication number
- ES2053815T3 ES2053815T3 ES88850319T ES88850319T ES2053815T3 ES 2053815 T3 ES2053815 T3 ES 2053815T3 ES 88850319 T ES88850319 T ES 88850319T ES 88850319 T ES88850319 T ES 88850319T ES 2053815 T3 ES2053815 T3 ES 2053815T3
- Authority
- ES
- Spain
- Prior art keywords
- preparation
- dihydropyridine
- antagonist
- beta
- adrenoreceptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- YNGDWRXWKFWCJY-UHFFFAOYSA-N 1,4-Dihydropyridine Chemical compound C1C=CNC=C1 YNGDWRXWKFWCJY-UHFFFAOYSA-N 0.000 title abstract 2
- 239000005557 antagonist Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 230000002035 prolonged effect Effects 0.000 title 1
- 238000013270 controlled release Methods 0.000 abstract 1
- RZTAMFZIAATZDJ-UHFFFAOYSA-N felodipine Chemical compound CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC(Cl)=C1Cl RZTAMFZIAATZDJ-UHFFFAOYSA-N 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- IUBSYMUCCVWXPE-UHFFFAOYSA-N metoprolol Chemical compound COCCC1=CC=C(OCC(O)CNC(C)C)C=C1 IUBSYMUCCVWXPE-UHFFFAOYSA-N 0.000 abstract 1
- 229960002237 metoprolol Drugs 0.000 abstract 1
- 238000013268 sustained release Methods 0.000 abstract 1
- 239000012730 sustained-release form Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
PREPARACION QUE DA UNA LIBERACION CONTROLADA Y SOSTENIDA DE UNA DIHIDROPIRIDINA, P.E. DE FELODIPINA, Y DE UN ANTAGONISTA DE BETA - ADRENORRECEPTORES, PRINCIPALMENTE METOPROLOL, Y METODO PARA SU FABRICACION.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8703881A SE8703881D0 (sv) | 1987-10-08 | 1987-10-08 | New pharmaceutical preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2053815T3 true ES2053815T3 (es) | 1994-08-01 |
Family
ID=20369795
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES88850319T Expired - Lifetime ES2053815T3 (es) | 1987-10-08 | 1988-09-22 | Preparacion farmaceutica con liberacion prolongada de una dihidropiridina y un antagonista de un beta-adrenorreceptor y un procedimiento para su preparacion. |
Country Status (26)
Country | Link |
---|---|
US (1) | US4942040A (es) |
EP (1) | EP0311582B1 (es) |
JP (1) | JP2619936B2 (es) |
KR (1) | KR960009411B1 (es) |
CN (1) | CN1029935C (es) |
AT (1) | ATE84412T1 (es) |
AU (1) | AU615211B2 (es) |
CA (1) | CA1312286C (es) |
CY (1) | CY1896A (es) |
DE (1) | DE3877492T2 (es) |
DK (1) | DK175085B1 (es) |
ES (1) | ES2053815T3 (es) |
FI (1) | FI92903C (es) |
GR (1) | GR3006788T3 (es) |
HK (1) | HK6296A (es) |
HU (1) | HU210461A9 (es) |
IE (1) | IE63084B1 (es) |
IL (1) | IL87922A (es) |
IS (1) | IS1584B (es) |
MX (1) | MX169243B (es) |
MY (1) | MY104065A (es) |
NO (1) | NO177375C (es) |
NZ (1) | NZ226245A (es) |
PH (1) | PH25568A (es) |
PT (1) | PT88711B (es) |
SE (1) | SE8703881D0 (es) |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5268182A (en) * | 1988-06-24 | 1993-12-07 | Abbott Laboratories | Sustained-release drug dosage units of terazosin |
GB9025251D0 (en) * | 1990-11-20 | 1991-01-02 | Solomon Montague C | Nifedipine dosage forms |
WO1992016197A1 (en) * | 1991-03-18 | 1992-10-01 | Sepracor Inc. | Composition and method containing optically pure (s) metoprolol |
US5834496A (en) * | 1991-12-02 | 1998-11-10 | Sepracor, Inc. | Methods for treating hypertension using optically pure S(-) felodipine |
IL104192A (en) * | 1992-02-17 | 1998-01-04 | Siegfried Ag Pharma | Pharmaceutical dosage forms having prolonged release rate of zero order of the active ingredient |
US5662933A (en) * | 1993-09-09 | 1997-09-02 | Edward Mendell Co., Inc. | Controlled release formulation (albuterol) |
US5773025A (en) * | 1993-09-09 | 1998-06-30 | Edward Mendell Co., Inc. | Sustained release heterodisperse hydrogel systems--amorphous drugs |
US5455046A (en) * | 1993-09-09 | 1995-10-03 | Edward Mendell Co., Inc. | Sustained release heterodisperse hydrogel systems for insoluble drugs |
US6726930B1 (en) * | 1993-09-09 | 2004-04-27 | Penwest Pharmaceuticals Co. | Sustained release heterodisperse hydrogel systems for insoluble drugs |
US6676967B1 (en) | 1993-09-20 | 2004-01-13 | Kos Pharmaceuticals, Inc. | Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia |
US6129930A (en) | 1993-09-20 | 2000-10-10 | Bova; David J. | Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night |
US6818229B1 (en) | 1993-09-20 | 2004-11-16 | Kos Pharmaceuticals, Inc. | Intermediate release nicotinic acid compositions for treating hyperlipidemia |
US6746691B2 (en) | 1993-09-20 | 2004-06-08 | Kos Pharmaceuticals, Inc. | Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics |
US6080428A (en) | 1993-09-20 | 2000-06-27 | Bova; David J. | Nicotinic acid compositions for treating hyperlipidemia and related methods therefor |
US5399358A (en) * | 1993-11-12 | 1995-03-21 | Edward Mendell Co., Inc. | Sustained release formulations for 24 hour release of metroprolol |
US5399359A (en) * | 1994-03-04 | 1995-03-21 | Edward Mendell Co., Inc. | Controlled release oxybutynin formulations |
US5399362A (en) * | 1994-04-25 | 1995-03-21 | Edward Mendell Co., Inc. | Once-a-day metoprolol oral dosage form |
HU219818B (hu) * | 1994-04-25 | 2001-08-28 | Edward Mendell Co. Inc. | Elnyújtott hatóanyag-leadású hordozóanyag |
US5478572A (en) * | 1994-09-06 | 1995-12-26 | Bristol-Myers Squibb Co. | Gepirone dosage form |
US5945125A (en) * | 1995-02-28 | 1999-08-31 | Temple University | Controlled release tablet |
WO1997026865A1 (en) * | 1996-01-29 | 1997-07-31 | Edward Mendell Co., Inc. | Sustained release excipient |
US5783212A (en) * | 1996-02-02 | 1998-07-21 | Temple University--of the Commonwealth System of Higher Education | Controlled release drug delivery system |
AU695734B2 (en) | 1996-07-08 | 1998-08-20 | Penwest Pharmaceuticals Co. | Sustained release matrix for high-dose insoluble drugs |
US6056977A (en) | 1997-10-15 | 2000-05-02 | Edward Mendell Co., Inc. | Once-a-day controlled release sulfonylurea formulation |
WO2000033818A1 (en) * | 1998-12-11 | 2000-06-15 | Nostrum Pharmaceuticals, Inc. | Sustained release tablet containing hydrocolloid and cellulose ether |
US6555139B2 (en) | 1999-06-28 | 2003-04-29 | Wockhardt Europe Limited | Preparation of micron-size pharmaceutical particles by microfluidization |
WO2001022940A1 (en) * | 1999-09-30 | 2001-04-05 | Edward Mendell Co., Inc. | Sustained release matrix systems for highly soluble drugs |
ATE526950T1 (de) | 1999-10-29 | 2011-10-15 | Euro Celtique Sa | Hydrocodon-formulierungen mit gesteuerter freisetzung |
US10179130B2 (en) | 1999-10-29 | 2019-01-15 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
DE60128683T2 (de) * | 2000-04-11 | 2008-01-24 | Sankyo Co., Ltd. | Stabilisierte pharmazeutische zusammenstellungen die den calziumkanalblocker azelnidipine enthalten |
US6375972B1 (en) | 2000-04-26 | 2002-04-23 | Control Delivery Systems, Inc. | Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
EP2263658A1 (en) | 2000-10-30 | 2010-12-22 | Euro-Celtique S.A. | Controlled release hydrocodone formulations |
CA2452871C (en) * | 2001-07-06 | 2011-10-04 | Endo Pharmaceuticals, Inc. | Oxymorphone controlled release formulations |
CA2459014C (en) * | 2001-09-14 | 2010-08-10 | Scolr, Inc. | Amino acid modulated extended release dosage form |
US20040009220A1 (en) * | 2001-12-31 | 2004-01-15 | Vinay Sharma | Rate-controlled beta blockers and process for forming same |
AU2003230805A1 (en) * | 2002-04-05 | 2003-10-27 | Penwest Pharmaceuticals Co. | Sustained release metoprolol formulations |
US8871241B2 (en) | 2002-05-07 | 2014-10-28 | Psivida Us, Inc. | Injectable sustained release delivery devices |
US20080051428A1 (en) * | 2002-05-15 | 2008-02-28 | Davis Paul J | Pyrroloquinoline quinone drugs and methods of use thereof |
US20050267143A1 (en) * | 2002-05-15 | 2005-12-01 | Davis Paul J | Pyrroloquinoline quinone drugs for treatment of cardiac injury and methods of use thereof |
US7276514B2 (en) * | 2002-05-15 | 2007-10-02 | Charitable Leadership Foundation - Medical Technology Acceleration Program | Pyrroloquinoline quinone drugs for treatment of cardiac injury and methods of use thereof |
KR20030095600A (ko) * | 2002-06-12 | 2003-12-24 | 환인제약 주식회사 | 펠로디핀을 포함하는 제어방출형 조성물 및 그 제조방법 |
US7314640B2 (en) * | 2003-07-11 | 2008-01-01 | Mongkol Sriwongjanya | Formulation and process for drug loaded cores |
US20070092573A1 (en) | 2005-10-24 | 2007-04-26 | Laxminarayan Joshi | Stabilized extended release pharmaceutical compositions comprising a beta-adrenoreceptor antagonist |
TW200806648A (en) * | 2005-11-29 | 2008-02-01 | Sankyo Co | Acid addition salts of dihydropyridine derivatives |
TW200736245A (en) * | 2005-11-29 | 2007-10-01 | Sankyo Co | Acid addition salts of optically active dihydropyridine derivatives |
US8445018B2 (en) | 2006-09-15 | 2013-05-21 | Cima Labs Inc. | Abuse resistant drug formulation |
DK2255791T3 (da) * | 2009-04-03 | 2012-03-05 | Zaklady Farmaceutyczne Polpharma Sa | Forlænget-frigivelse-farmaceutisk sammensætning omfattende metoprololsuccinat |
JP2013526523A (ja) * | 2010-05-11 | 2013-06-24 | シマ ラブス インク. | メトプロロールを含むアルコール耐性持続放出性経口剤形 |
CN102883713B (zh) * | 2010-05-11 | 2016-08-03 | 思玛化验室公司 | 耐醇型制剂 |
CN103906508A (zh) * | 2011-08-26 | 2014-07-02 | 沃克哈特有限公司 | 治疗心血管疾病的方法 |
GB2512059B (en) * | 2013-03-18 | 2016-08-31 | Rolls Royce Plc | An independently moveable machine tool |
CN113143877A (zh) * | 2021-05-07 | 2021-07-23 | 苏州康恒研新药物技术有限公司 | 一种琥珀酸美托洛尔微丸缓释片的制备方法 |
CN114712319B (zh) * | 2022-03-25 | 2024-01-09 | 北京诺康达医药科技股份有限公司 | 一种非洛地平盐酸普萘洛尔复方制剂及其制备方法 |
Family Cites Families (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3870790A (en) * | 1970-01-22 | 1975-03-11 | Forest Laboratories | Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose |
CH532038A (de) * | 1970-05-25 | 1972-12-31 | Ciba Geigy Ag | Verfahren zur Herstellung von neuen Cycloheptenderivaten |
US3951821A (en) * | 1972-07-14 | 1976-04-20 | The Dow Chemical Company | Disintegrating agent for tablets |
US4123382A (en) * | 1973-05-25 | 1978-10-31 | Merck & Co., Inc. | Method of microencapsulation |
DE2336218C3 (de) * | 1973-07-17 | 1985-11-14 | Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz | Orale Arzneiform |
SE418247B (sv) * | 1975-11-17 | 1981-05-18 | Haessle Ab | Sett att framstella kroppar med reglerad frigoring av en aktiv komponent |
US4016880A (en) * | 1976-03-04 | 1977-04-12 | Alza Corporation | Osmotically driven active agent dispenser |
US4291016A (en) * | 1976-07-27 | 1981-09-22 | Sandoz Ltd. | Enteric coated mixture of 4-(2-hydroxy-3-isopropylamino-propoxy) indole and sodium lauryl sulphate |
GB1542414A (en) * | 1976-08-19 | 1979-03-21 | Standard Telephones Cables Ltd | Arrangements for the controlled release of biologically active materials |
DE2642032C2 (de) * | 1976-09-18 | 1987-04-30 | Rupprecht, Herbert, Prof. Dr., 8400 Regensburg | Verfahren zur Inkorporierung von Wirkstoffen in siliciumdioxidhaltige Trägermaterialien und eine siliciumdioxidhaltige Zubereitung |
GB1576376A (en) * | 1977-03-30 | 1980-10-08 | Benzon As Alfred | Multiple-unit drug dose |
US4256108A (en) * | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
SE426548B (sv) * | 1978-12-05 | 1983-01-31 | Haessle Ab | Fast farmaceutisk beredning innehallande en terapeutiskt effektiv hjertglykosid och en polymer |
US4357469A (en) * | 1979-06-14 | 1982-11-02 | Forest Laboratories, Inc. | Carrier base material for prolonged release therapeutic compositions |
US4226849A (en) * | 1979-06-14 | 1980-10-07 | Forest Laboratories Inc. | Sustained release therapeutic compositions |
CA1146866A (en) * | 1979-07-05 | 1983-05-24 | Yamanouchi Pharmaceutical Co. Ltd. | Process for the production of sustained release pharmaceutical composition of solid medical material |
US4309406A (en) * | 1979-07-10 | 1982-01-05 | American Home Products Corporation | Sustained release pharmaceutical compositions |
US4309404A (en) * | 1979-08-09 | 1982-01-05 | American Home Products Corporation | Sustained release pharmaceutical compositions |
US4259314A (en) * | 1979-12-10 | 1981-03-31 | Hans Lowey | Method and composition for the preparation of controlled long-acting pharmaceuticals |
DE3033919A1 (de) * | 1980-09-09 | 1982-04-22 | Bayer Ag, 5090 Leverkusen | Feste arzneizubereitungen enthaltend nifedipin und verfahren zu ihrer herstellung |
CH655658B (es) * | 1980-09-18 | 1986-05-15 | ||
US4326525A (en) * | 1980-10-14 | 1982-04-27 | Alza Corporation | Osmotic device that improves delivery properties of agent in situ |
US4439195A (en) * | 1980-10-14 | 1984-03-27 | Alza Corporation | Theophylline therapy |
US4428883A (en) * | 1981-03-06 | 1984-01-31 | The University Of Kentucky Research Foundation | Novel method of administering β-blockers and novel dosage forms containing same |
IT1144911B (it) * | 1981-03-19 | 1986-10-29 | Pharmatec Spa | Composizione farmaceutica a rilascio controllato contenente ibuprofen |
GB2098867B (en) * | 1981-05-21 | 1984-10-24 | Wyeth John & Brother Ltd | Sustained release pharmaceutical composition |
JPS57209223A (en) * | 1981-06-19 | 1982-12-22 | Tanabe Seiyaku Co Ltd | Microcapsule for intracranial anti hypotension and its production |
US4369272A (en) * | 1981-07-07 | 1983-01-18 | E. I. Du Pont De Nemours And Company | Process for preparing polyolefin resin extended pigments comprising salt milling crude pigment with the resin |
US4484921A (en) * | 1982-02-01 | 1984-11-27 | Alza Corporation | Theophylline therapy utilizing osmotic delivery |
US4434153A (en) * | 1982-03-22 | 1984-02-28 | Alza Corporation | Drug delivery system comprising a reservoir containing a plurality of tiny pills |
US4649043A (en) * | 1982-03-22 | 1987-03-10 | Alza Corporation | Drug delivery system for delivering a plurality of tiny pills in the gastrointestinal tract |
US4642233A (en) * | 1982-03-22 | 1987-02-10 | Alza Corporation | Gastrointestinal drug delivery system comprising a hydrogel reservoir containing a plurality of tiny pills |
US4449983A (en) * | 1982-03-22 | 1984-05-22 | Alza Corporation | Simultaneous delivery of two drugs from unit delivery device |
JPS58170712A (ja) * | 1982-03-31 | 1983-10-07 | Chiyoda Yakuhin Kk | インドメタシン徐放錠 |
US4415547A (en) * | 1982-06-14 | 1983-11-15 | Sterling Drug Inc. | Sustained-release pharmaceutical tablet and process for preparation thereof |
DE3247118A1 (de) * | 1982-12-20 | 1984-06-20 | Cassella Ag, 6000 Frankfurt | Neue substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
US4578075A (en) * | 1982-12-20 | 1986-03-25 | Alza Corporation | Delivery system housing a plurality of delivery devices |
US4681583A (en) * | 1982-12-20 | 1987-07-21 | Alza Corporation | System for dispersing drug in biological environment |
DE3307422A1 (de) * | 1983-03-03 | 1984-09-06 | Bayer Ag, 5090 Leverkusen | Fluessigzubereitungen von dihydropyridinen, ein verfahren zu ihrer herstellung, sowie ihre verwendung bei der bekaempfung von erkrankungen |
PH18946A (en) * | 1983-04-21 | 1985-11-14 | Elan Corp Plc | Controlled absorption pharmaceutical composition |
GB2146531B (en) * | 1983-09-15 | 1987-04-29 | Stc Plc | Controlled release system |
SE457505B (sv) * | 1984-01-10 | 1989-01-09 | Lejus Medical Ab | Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning |
IE59287B1 (en) * | 1984-02-10 | 1994-02-09 | Benzon Pharma As | Diffusion coated multiple-units dosage form |
GB2154874B (en) * | 1984-02-29 | 1987-11-04 | Sandoz Ltd | Bromoscriptine compositions |
IT1206166B (it) * | 1984-07-26 | 1989-04-14 | Sigma Tau Ind Farmaceuti | Dispositivo per rilasciare una sostanza in un fluido di dissoluzione con cinetica di ordine zero e procedimento per la sua preparazione |
US4794111A (en) * | 1984-05-23 | 1988-12-27 | Bayer Aktiengesellschaft | Dihydropyridine preparations containing β-blockers |
DE3419131A1 (de) * | 1984-05-23 | 1985-11-28 | Bayer Ag, 5090 Leverkusen | Dihydropyridinkombinationspraeparate und verfahren zu ihrer herstellung |
GB2159715B (en) * | 1984-06-04 | 1988-05-05 | Sterwin Ag | Pharmaceutical composition in sustained release unit dose form and process for its preparation |
SE455836B (sv) * | 1985-10-11 | 1988-08-15 | Haessle Ab | Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning |
US4808413A (en) * | 1987-04-28 | 1989-02-28 | E. R. Squibb & Sons, Inc. | Pharmaceutical compositions in the form of beadlets and method |
-
1987
- 1987-10-08 SE SE8703881A patent/SE8703881D0/xx unknown
-
1988
- 1988-09-16 AU AU22374/88A patent/AU615211B2/en not_active Expired
- 1988-09-20 NZ NZ226245A patent/NZ226245A/xx unknown
- 1988-09-22 AT AT88850319T patent/ATE84412T1/de not_active IP Right Cessation
- 1988-09-22 EP EP88850319A patent/EP0311582B1/en not_active Expired - Lifetime
- 1988-09-22 DE DE8888850319T patent/DE3877492T2/de not_active Expired - Lifetime
- 1988-09-22 ES ES88850319T patent/ES2053815T3/es not_active Expired - Lifetime
- 1988-09-27 IE IE292188A patent/IE63084B1/en not_active IP Right Cessation
- 1988-09-27 NO NO884269A patent/NO177375C/no not_active IP Right Cessation
- 1988-09-29 US US07/250,945 patent/US4942040A/en not_active Expired - Lifetime
- 1988-09-29 PH PH37615A patent/PH25568A/en unknown
- 1988-10-05 IL IL87922A patent/IL87922A/xx active Protection Beyond IP Right Term
- 1988-10-06 DK DK198805586A patent/DK175085B1/da active
- 1988-10-06 MX MX013316A patent/MX169243B/es unknown
- 1988-10-06 MY MYPI88001120A patent/MY104065A/en unknown
- 1988-10-06 IS IS3398A patent/IS1584B/is unknown
- 1988-10-07 FI FI884636A patent/FI92903C/fi not_active IP Right Cessation
- 1988-10-07 PT PT88711A patent/PT88711B/pt not_active IP Right Cessation
- 1988-10-07 KR KR88013076A patent/KR960009411B1/ko not_active IP Right Cessation
- 1988-10-07 CA CA000579566A patent/CA1312286C/en not_active Expired - Lifetime
- 1988-10-07 JP JP63252209A patent/JP2619936B2/ja not_active Expired - Lifetime
- 1988-10-08 CN CN88109129A patent/CN1029935C/zh not_active Expired - Lifetime
-
1993
- 1993-01-14 GR GR930400002T patent/GR3006788T3/el unknown
-
1994
- 1994-12-15 HU HU94P/P00056P patent/HU210461A9/hu unknown
-
1996
- 1996-01-11 HK HK6296A patent/HK6296A/xx not_active IP Right Cessation
- 1996-09-27 CY CY189696A patent/CY1896A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2053815T3 (es) | Preparacion farmaceutica con liberacion prolongada de una dihidropiridina y un antagonista de un beta-adrenorreceptor y un procedimiento para su preparacion. | |
ES550807A0 (es) | Un procedimiento para la produccion de un preparado farmaceutico de liberacion lenta y controlada. | |
ES2103563T3 (es) | Esteres nitricos con una actividad farmacologica y procedimiento para su preparacion. | |
ES2037385T3 (es) | Un procedimiento de manufactura de una preparacion farmaceutica para administracion local. | |
IT8820145A0 (it) | Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione. | |
ES2053719T3 (es) | Dimetilvermectinas no naturales y procedimiento para su preparacion. | |
IT1230182B (it) | Metodo ed apparato per riparare o fabbricare un oggetto.avente un supporto ed una sporgenza solidali | |
DE3886965D1 (de) | Zubereitungen zur gesteuerten Wirkstofffreisetzung. | |
ES503011A0 (es) | Un procedimiento para la preparacion de una formulacion por-tadora de farmacos,biodegradable y magneticamente localiza- ble | |
MX9200374A (es) | Nuevos esteres esteroides, procedimiento para su preparacion y preparacion farmaceutica que los contiene. | |
ES534531A0 (es) | Un procedimiento para la preparacion de una composicion a base de agente tensioactivo no ionico y-o anionico-acido hidrocarbil-carboxilico. | |
AR240303A1 (es) | Una silice, procedimiento para su preparacion y composicion dentifrica que la contiene. | |
MX9102580A (es) | Nuevas benzodiacepinonas, procedimiento para su preparacion y composicion farmaceutica que las contiene. | |
ES2014392A4 (es) | Procedimiento para la fabricacion de peroxido de hidrogeno. | |
DE68908204D1 (de) | Nachrichtenverteilungssystem. | |
AR240018A1 (es) | Procedimiento para preparar una composicion que comprende derivados de piperidinoalcanol. | |
ES551635A0 (es) | Procedimiento para la obtencion de una composicion farmaceutica de liberacion retardada a base de 9,10-dihidro-alcaloides. | |
ES542846A0 (es) | Procedimiento para producir un preparado farmaceutico desti-nado a aplicacion por via topica | |
NO885406D0 (no) | Fremgangsmaate for fremstilling av 4-heteroaryl-1,3-benzodiazepiner og 2-substituerte-alfa-(hetero-aryl)benzenetanaminer og anvendelse derav som medikamenter. | |
ES548889A0 (es) | Un procedimiento para preparar una vacuna anti-helmintica que comprende una suspension, homogeneizado o extracto de una especie de nematodo y un vehiculo farmaceutico. | |
ES2058478T3 (es) | Procedimiento para la preparacion de trans-beta-lactamas. | |
IT8721055A0 (it) | Derivati prostaglandinici, procedimenti per prepararli e composizioni farmaceutiche che licontengono. | |
ES2141044B1 (es) | Terapia con oxibutinina. | |
AR240249A1 (es) | Procedimiento para la obtenicon de una preparacion de liberacion controlada y procedimientos para obtener composicion que incluyen dichas preparaciones. | |
ES549868A0 (es) | Procedimiento para preparar una composicion farmaceutica a base de sulpirida y un progestageno. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 311582 Country of ref document: ES |